Pericles Calias - Net Worth and Insider Trading
Pericles Calias Net Worth
The estimated net worth of Pericles Calias is at least $164 dollars as of 2024-09-20. Pericles Calias is the Chief Scientific Officer of Avalo Therapeutics Inc and owns about 18 shares of Avalo Therapeutics Inc (AVTX) stock worth over $164. Details can be seen in Pericles Calias's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Pericles Calias has not made any transactions after 2019-12-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Pericles Calias
Pericles Calias Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pericles Calias owns 1 companies in total, including Avalo Therapeutics Inc (AVTX) .
Click here to see the complete history of Pericles Calias’s form 4 insider trades.
Insider Ownership Summary of Pericles Calias
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVTX | Avalo Therapeutics Inc | 2019-12-10 | Chief Scientific Officer |
Pericles Calias Latest Holdings Summary
Pericles Calias currently owns a total of 1 stock. Pericles Calias owns 18 shares of Avalo Therapeutics Inc (AVTX) as of December 10, 2019, with a value of $164.
Latest Holdings of Pericles Calias
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AVTX | Avalo Therapeutics Inc | 2019-12-10 | 18 | 9.11 | 164 |
Holding Weightings of Pericles Calias
Pericles Calias Form 4 Trading Tracker
According to the SEC Form 4 filings, Pericles Calias has made a total of 1 transactions in Avalo Therapeutics Inc (AVTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Avalo Therapeutics Inc is the acquisition of 1 shares on December 10, 2019, which cost Pericles Calias around $8,302.
Insider Trading History of Pericles Calias
- 1
Pericles Calias Trading Performance
GuruFocus tracks the stock performance after each of Pericles Calias's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Pericles Calias is -30.09%. GuruFocus also compares Pericles Calias's trading performance to market benchmark return within the same time period. The performance of stocks bought by Pericles Calias within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Pericles Calias's insider trading performs compared to the benchmark.
Performance of Pericles Calias
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 18.41 | | | | | |
| Relative Return to S&P 500(%) | 14.45 | | | | | |
Pericles Calias Ownership Network
Pericles Calias Owned Company Details
What does Avalo Therapeutics Inc do?
Who are the key executives at Avalo Therapeutics Inc?
Pericles Calias is the Chief Scientific Officer of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Interim CFO Christopher Ryan Sullivan .
Avalo Therapeutics Inc (AVTX) Insider Trades Summary
Over the past 18 months, Pericles Calias made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 206,169 shares made by Caissa Capital Management Ltd. , a net sale of 3,683,542 shares made by Armistice Capital Master Fund Ltd. , and a net purchase of 4,000 shares made by Garry Arthur Neil .
In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,348 shares of Avalo Therapeutics Inc (AVTX) were sold and 878 shares were bought by its insiders, resulting in a net sale of 14,470 shares.
Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avalo Therapeutics Inc Insider Transactions
Pericles Calias Mailing Address
Above is the net worth, insider trading, and ownership report for Pericles Calias. You might contact Pericles Calias via mailing address: C/o Cerecor Inc., 400 East Pratt Street, Suite 606, Baltimore Md 21202.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
